Skip to main content

Table 1 Baseline characteristics of pregnant women with malaria episode Nchelenge, Zambia (2010–2014)

From: Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria

 

AL (N = 300)

MQAS (N = 300)

DHAPQ (N = 300)

Age (years): median (IQR)

20 (18–24)

19 (18–24)

20 (18–24)

Symptomatic malaria (%)

46.0

48.7

52.7

 Fever (temperature ≥ 37.5 °C) (%)

2.0

3.3

3.7

 Parasite density >2000/µL (%)

41.0

42.7

45.7

 At least 3 symptomsa (%)

11.0

12.3

12.0

Gametocytes present (%)

2.3

0

1.3

Parasite density (/µL): median (IQR)

1360 (480–4280)

1610 (540–4340)

1640 (520–4880)

Haemoglobin (g/dL): median (IQR)

10.0 (9.1–11.0)

10.0 (9.0–10.9)

10.0 (9.2–10.9)

Gravidity

 1st Pregnancy (%)

33.3

35.7

31.3

 2nd Pregnancy (%)

30.3

30.3

32.0

 3rd Pregnancy or more (%)

36.3

34.0

36.7

Gestational ageb

 2nd Trimester (%)

50.0

50.0

43.7

 3rd Trimester (%)

50.0

50.0

56.3

Bed net used before study entry (%)

30.7

28.7

27.3

ITN used before study entryc (%)

25.3

21.0

22.7

 IPT use (before day 0) (%)

9.7

7.0

11.7

  1. aAt least 3 or more of the following symptoms: fever in the past 24 h, weakness/fatigue; muscle and/or joint aches, headache, convulsion, with parasitaemia of any density
  2. b2nd Trimester were patients ≤24 weeks gestation and 3rd trimester >24 weeks gestation
  3. cWomen were provided with ITN at study start